Literature DB >> 7883216

Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum.

S Khulusi1, M A Mendall, S Badve, P Patel, C Finlayson, T C Northfield.   

Abstract

Helicobacter pylori associated duodenal ulcers occur in patches of gastric metaplasia. The pathogenesis of gastric metaplasia is unclear, but it has been produced in experimental animals by acute injury and has been shown to be present to a greater extent of H pylori positive subjects. This study aimed to discover if gastric metaplasia regressed with eradication of H pylori or healing of duodenal ulcers, or both. Thirty two duodenal ulcer patients with H pylori infection confirmed by biopsy urease test and by antral histological examination were studied. Patients were treated with triple therapy (deNol 240 mg twice daily, amoxycillin 500 mg three times daily, and metronidazole 400 mg three times daily) for two weeks after the first endoscopy and were subsequently re-endoscoped. Three duodenal bulb biopsy specimens were obtained per patient at each endoscopy. Biopsy sections were stained with haematoxylin and eosin to determine the severity of duodenitis, and with diastase periodic acid-Schiff/alcian blue to assess the extent of gastric metaplasia. Slides were assessed by two histopathologists unaware of treatment status. H pylori was eradicated in 63% of subjects and all ulcers were healed at follow up. The median extent of gastric metaplasia at the start of treatment and 6-18 months (median 10) after treatment was compared in the two groups. Gastric metaplasia declined in eradicators from 16% to 8% (p < 0.05) while in non-eradicators there was no significant change (25% initially and at follow up). A positive relation between extent of gastric metaplasia and duodenal inflammation score was present before treatment (r(s) = 0.74, p < 0.001) and was unchanged after treatment in the non-eradicator group (r(s) = 0.89, p < 0.001). In the eradicator group, however, the inflammation score had significantly declined (p < 0.02) and the close relation with gastric metaplasia was no longer present. These results suggest that H pylori itself is at least in part responsible for producing gastric metaplasia of the duodenum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883216      PMCID: PMC1382403          DOI: 10.1136/gut.36.2.193

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group.

Authors: 
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

2.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

3.  Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population.

Authors:  P L Fitzgibbons; C P Dooley; H Cohen; M D Appleman
Journal:  Am J Clin Pathol       Date:  1988-12       Impact factor: 2.493

4.  Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

Authors:  D Y Graham; G M Lew; P D Klein; D G Evans; D J Evans; Z A Saeed; H M Malaty
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

Review 5.  The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.

Authors:  E Bayerdörffer; R Ottenjann
Journal:  Scand J Gastroenterol Suppl       Date:  1988

6.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

7.  Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease.

Authors:  K A Jönsson; M Ström; G Bodemar; K Norrby
Journal:  Scand J Gastroenterol       Date:  1988-05       Impact factor: 2.423

8.  High incidence of Campylobacter-like organisms in endoscopic biopsies from patients with gastritis, with or without peptic ulcer.

Authors:  R Fiocca; L Villani; F Turpini; R Turpini; E Solcia
Journal:  Digestion       Date:  1987       Impact factor: 3.216

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Gastric metaplasia and Helicobacter pylori infection.

Authors:  L A Noach; T M Rolf; N B Bosma; M P Schwartz; J Oosting; E A Rauws; G N Tytgat
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  5 in total

1.  Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; G Bisso; M Pivari; C Mansi; L Tessieri; G Lapertosa; P Ceppa; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

2.  Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; L Lapertosa; R Patetta; E Dallorto; A Vassallo; C Mansi; S Vigneri; G Celle
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

3.  Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb.

Authors:  A W Harris; P A Gummett; M M Walker; J J Misiewicz; J H Baron
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.

Authors:  S Khulusi; M A Mendall; P Patel; J Levy; S Badve; T C Northfield
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

5.  Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers.

Authors:  S Khulusi; A M Hanby; J M Marrero; P Patel; M A Mendall; S Badve; R Poulsom; G Elia; N A Wright; T C Northfield
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.